CampusAI is like “Coursera meets Github meets Tinder in the metaverse” — an educational platform focused on making learning accessible to everyday people who want to bring AI into their everyday workflows, and a virtual ecosystem to connect like-minded people.
The goal is faster, cheaper, and more reliable risk evaluation for spacecraft insurance, and eventually to power new forms of credit and nondilutive funding for space companies looking outside venture capital and the public markets.
Tina Williams-Koroma said CyDeploy uses machine learning to understand what happens on a company’s machine and then creates a “digital twin” where system administrators can test updates.
Cyphr's product analyzes alternative data sources and financial patterns of small businesses to help lenders make decisions about small business creditworthiness.
Elloe AI promises a system capable of fact-checking AI outputs, making sure they don’t violate laws and regulations, and that they are safe for the users.
Strong by Form has designed a structural floor piece that can span longer distances than existing engineered wood, making it a replacement for steel or concrete. At the same time, the product is lighter than all three.
MacroCycle's approach to recycling dramatically reduces the amount of energy needed to produce new material, potentially lowering costs to the point where it could compete with virgin plastic.
Damoa pinpointed the problem: the complex, multi-step process moving a container from a ship to a freight train. He founded Glīd Technologies to try and solve it.
The company's so-called Pathfinder software can look at almost anything — buildings, tree-lined roads, even aerial views — and quickly match it to a database and generate real-time navigation.
“What we really do is we took the most constrained, complex, and costly medical imaging solution in radiology, and we supplanted it with what is the most accessible, simple and affordable, which is CT,” Sean Walsh, RADiCAIT’s CEO told TechCrunch.
Although Maxim was convinced that gene therapy could reverse PKD, the biggest hurdle was creating a mechanism to deliver the drugs directly to the diseased cells.
These 20 companies are more than just early-stage startups — they’re the architects of what’s next. And they’ll have just six minutes on the Disrupt Stage to prove it.